ClinConnect ClinConnect Logo
Search / Trial NCT06538714

Interval Training and Cardio-metabolic Health in Overweight/Obese Girls

Launched by ASSOCIATION TUNISIENNE D'ETUDE & DE RECHERCHE SUR L'ATHÉROSCLÉROSE · Jul 31, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Interval Training Obesity Overweight Childhood Cardiometabolic Risk Enjoyement Lipidomics Body Composition Physical Fitness

ClinConnect Summary

This clinical trial is looking at how different types of exercise can affect the health of overweight and obese girls aged 12 to 15. Specifically, the study compares two exercise programs: one that involves moderate-intensity interval training (MIIT) and another that combines MIIT with high-intensity interval training (HIIT). Researchers want to see how these workouts impact physical fitness, heart health, and even mood and enjoyment of exercise over a 12-week period.

To participate in this study, girls must be female, aged 12 to 15, and classified as overweight or obese based on their body mass index (BMI). They should not have any serious health issues, irregular menstrual cycles, or be involved in organized exercise training for at least six months. Participants will receive consent forms that need to be signed by a parent or guardian. Throughout the trial, girls can expect to engage in structured exercise sessions and may notice improvements in their fitness and overall well-being.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female gender,
  • Overweight or obese according to the BMI classification,
  • Age, 12 to 15 years,
  • Personal or parental/guardian written consent
  • Exclusion Criteria:
  • Severe infectious or inflammatory diseases,
  • Irregular menstrual cycles
  • Participation in organized exercise training in the last 6 months or additional physical -
  • recreational activities, except physical education classes.
  • Using medications, hormone therapy or dietary supplements

About Association Tunisienne D'etude & De Recherche Sur L'athérosclérose

The Association Tunisienne d'Étude & de Recherche sur l'Athérosclérose (ATERA) is a leading clinical trial sponsor dedicated to advancing research and understanding of atherosclerosis and related cardiovascular conditions. Committed to fostering innovation and collaboration in the field of cardiovascular health, ATERA engages in rigorous scientific studies aimed at improving prevention, diagnosis, and treatment strategies. The association brings together a multidisciplinary team of researchers, healthcare professionals, and industry partners to contribute to the global body of knowledge on atherosclerosis, ultimately striving to enhance patient outcomes and public health in Tunisia and beyond.

Locations

Tunis, , Tunisia

Tunis, , Tunisia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported